- Research works
- 24 ▼ 19% vs 2013–17
- Citations
- 1.2k 50.4 per fractional work
- Top-10% rate
- 12.2% record average 16.5%
- Open access
- 46% world 28%
Not ranked overall: Biofrontera (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 3.8×. Every wedge is a field page.
Which keywords describe research at Biofrontera (Germany)?
By fractional works in all years, weighted toward what it does more of than the world: Neurodegeneration, Parkinson's Disease, Dopaminergic Neurons, Oxidative Stress, Photodynamic Therapy, Mitochondrial Dysfunction, a-Synuclein and Genetic Risk Factors.
- Skin Cancers
- Cell Signaling
- Basal Cell Carcinoma
- Gene Expression
- Photosensitizers
- Cancer Treatment
- NR4A2
- Neuroinflammation
- Nanoparticles
- Reactive Oxygen Species
- Apoptosis
- Genetic Risk Factors
- Inflammation
- Oxidative Stress
- Parkinson's Disease
- Neurodegeneration
- Dopaminergic Neurons
- Photodynamic Therapy
- Mitochondrial Dysfunction
- a-Synuclein
- Transcriptional Regulation
- Metastasis
- Secondary Metabolites
- Nuclear Receptors
- Nurr1
- Innate Immunity
- Cancer
- Natural Products
- Brain Development
- Nonmelanoma Skin Cancer
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 30 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 30 words, with their numbers
- Neurodegeneration6▲ 80×8 topics
- Parkinson's Disease4▲ 74×4 topics
- Dopaminergic Neurons4▲ 245×2 topics
- Oxidative Stress4▲ 8.1×6 topics
- Photodynamic Therapy3▲ 75×3 topics
- Inflammation3▲ 4.7×8 topics
- Mitochondrial Dysfunction2▲ 28×3 topics
- Genetic Risk Factors2▲ 191×1 topic
- a-Synuclein2▲ 191×1 topic
- Apoptosis2▲ 22×5 topics
- Transcriptional Regulation2▲ 34×4 topics
- Reactive Oxygen Species2▲ 15×3 topics
- Metastasis2▲ 22×3 topics
- Nanoparticles2▲ 5.5×2 topics
- Secondary Metabolites2▲ 73×2 topics
- Neuroinflammation2▲ 25×3 topics
- Nuclear Receptors2▲ 36×2 topics
- NR4A22▲ 429×1 topic
- Nurr12▲ 429×1 topic
- Cancer Treatment1▲ 21×1 topic
- Innate Immunity1▲ 16×4 topics
- Photosensitizers1▲ 223×1 topic
- Cancer1▲ 3.8×8 topics
- Gene Expression1▲ 8.3×5 topics
- Natural Products1▲ 28×2 topics
- Basal Cell Carcinoma1▲ 117×2 topics
- Brain Development1▲ 23×3 topics
- Cell Signaling1▲ 14×5 topics
- Nonmelanoma Skin Cancer1▲ 203×1 topic
- Skin Cancers1▲ 203×1 topic
Which research topics does Biofrontera (Germany) publish most on?
By volume in 2022–2025: Nonmelanoma Skin Cancer Studies, Photodynamic Therapy Research Studies, Cutaneous Melanoma Detection and Management and Migraine and Headache Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Nonmelanoma Skin Cancer Studies Epidemiology 1 works
- 2 Photodynamic Therapy Research Studies Pulmonary and Respiratory Medicine 0 works
- 3 Cutaneous Melanoma Detection and Management Oncology 0 works
- 4 Migraine and Headache Studies Psychiatry and Mental health 0 works
- 5 Pituitary Gland Disorders and Treatments Endocrinology, Diabetes and Metabolism 0 works
- 6 Aldose Reductase and Taurine Cell Biology 0 works
- 7 Porphyrin Metabolism and Disorders Molecular Biology 0 works
- 8 Social Media in Health Education Health 0 works
- 9 Parkinson's Disease Mechanisms and Treatments Neurology 0 works
- 10 Neuroscience and Neural Engineering Cellular and Molecular Neuroscience 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Biofrontera (Germany)'s research output changed?
Output in 2018–2022 was 19% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Leverkusen
- Bayer (Germany)
- Klinikum Leverkusen
- Covestro (Germany)
- Agfa-Gevaert (Germany)
- St. Remigius Krankenhaus Opladen
- ClinAssess (Germany)
- KRONOS (Germany)
- Novasep (Germany)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.